ALBUMIN, IODINATED I 125 SERUM
drug drugOn this page
Also known as 125 i hsa125 i-hsaAlbumin iodinated i-125 serumAlbuminiodinated i 125 serumiodinated i-125 serumiodinated serumi-125Albumotope i-125Hsa i-125Human albumin i-125Human serum albumin i-125Iodinated (125 i) human serum albuminIodinated (125i) human serum albuminIodinated i 125 serum albuminIodinated i-125 serum albuminIodine (125i) human albuminJeanatopeRisa-125Seroalbumina humana iodada (125i)
Summary
Albumin, Iodinated I 125 Serum (CHEMBL1201452) is an approved protein (ATC V09GB02).
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Protein
- ATC class: V09GB02
- Clinical trials: 1
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201452 |
| Name | ALBUMIN, IODINATED I 125 SERUM |
| Type | Protein |
| Max phase | 4 |
| ATC | V09GB02 |
Also known as: 125 i hsa, 125 i-hsa, Albumin iodinated i-125 serum, Albumin, iodinated i 125 serum, iodinated i-125 serum, iodinated serum, i-125, Albumotope i-125, Hsa i-125, Human albumin i-125, Human serum albumin i-125
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
0 indication records carry no mapped disease name (EFO/MeSH-only); none shown.
Clinical trials
Total trials: 1.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT01686776 | PHASE3 | COMPLETED | A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.